
Loading, please wait...

Loading, please wait...

MXenes are a revolutionary class of two-dimensional (2D) nanomaterials that are currently transforming the landscape of precision medicine. These materials consist of transition metal carbides, nitrides, or carbonitrides. Consequently, they possess exceptional electronic conductivity and surface reactivity. Researchers are increasingly focusing on MXene-based theranostics because these nanostructures offer a unique combination of hydrophilicity and mechanical robustness. By integrating these materials into bioengineered composites, clinicians can potentially access more effective diagnostic and therapeutic tools.
The synthesis of bioengineered MXene-polymer-metal composites relies on sophisticated surface engineering. Because MXenes have a high surface-to-volume ratio, they allow for extensive functionalization with various polymers and metal oxides. This structural versatility creates a synergistic effect that enhances biocompatibility. Furthermore, the atomic configuration and surface terminations directly influence how these materials interact with biological systems. Therefore, careful design is essential to optimize their performance in complex physiological environments.
One of the most promising applications for these materials lies in the field of oncology. MXene-based theranostics enable a dual-purpose approach where a single agent handles both imaging and treatment. For example, MXene composites can serve as highly sensitive biosensors while simultaneously delivering targeted drug payloads to tumor cells. Additionally, their ability to absorb near-infrared light makes them excellent candidates for photothermal therapy. This multimodal capability reduces the need for multiple interventions, which often improves patient compliance and clinical outcomes.
Beyond traditional drug delivery, scientists are developing stimuli-responsive MXene platforms known as MXenzymes. These bioengineered systems react to specific internal triggers, such as pH changes or enzymatic activity within the tumor microenvironment. Consequently, the release of therapeutic agents becomes highly localized. This precision minimizes damage to healthy tissues. Although challenges regarding clinical translation remain, the roadmap for these next-generation nanoconjugates looks promising for targeted therapeutics.
MXenes offer high electrical conductivity and a large surface area for drug loading. They are particularly effective in photothermal therapy and multimodal imaging, allowing clinicians to track and treat tumors simultaneously.
Integrating polymers and metal oxides enhances the stability and biocompatibility of MXenes. These additions also provide synergistic effects, such as improved mechanical strength and enhanced contrast for radiology applications.
While preclinical research is robust and shows significant potential, most MXene-based nanoconjugates are currently in the advanced research phase. Ongoing studies are addressing toxicity and long-term clearance to pave the way for human clinical translation.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. The field of nanomaterials is rapidly evolving. Refer to the latest local and national guidelines for clinical practice.
References
1. Alsardi MM et al. Bioengineered MXene-Polymer-Metal Composites: From Synthesis and Structure to Multimodal Diagnostic and Therapeutic Applications. Adv Healthc Mater. 2026 Feb 15. doi: 10.1002/adhm.202504390. PMID: 41691434.
2. Zamani M, et al. MXenes in Cancer Nanotheranostics. Nanomaterials. 2022 Sep 27;12(19):3360. doi: 10.3390/nano12193360. PMID: 36234487.
3. Lin H, et al. Photodynamic Therapy Based on Graphene and MXene in Cancer Theranostics. Frontiers in Chemistry. 2019 Oct 25. doi: 10.3389/fchem.2019.00760.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review of bioengineered MXene-based composites for multimodal bioimaging, biosensing, and targeted tumor therapy in clinical applications....
5 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today